Richard A. Heyman's Net Worth
$26.2 Million
Who is Richard A. Heyman?
Richard A. Heyman has an estimated net worth of $26.2 Million. This is based on reported shares across multiple companies, which include Enliven Therapeutics, Inc., Receptos, Inc., PMV Pharmaceuticals, Inc., Gritstone Oncology, Inc., BCTG Acquisition Corp., ORGANOVO HOLDINGS, INC., Metacrine, Inc., Oric Pharmaceuticals, Inc., YUMANITY THERAPEUTICS, INC., and RayzeBio, Inc..
SEC CIK
Richard A. Heyman's CIK is 0001584759
Past Insider Trading and Trends
2021 was Richard A. Heyman's most active year for acquiring shares with 7 total transactions. Richard A. Heyman's most active month to acquire stocks was the month of May. 2024 was Richard A. Heyman's most active year for disposing of shares, totalling 13 transactions. Richard A. Heyman's most active month to dispose stocks was the month of July. 2023 saw Richard A. Heyman paying a total of $0.00 for 246,935 shares, this is the most they've acquired in one year. In 2024 Richard A. Heyman cashed out on 384,353 shares for a total of $23,343,678.81, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Enliven Therapeutics, Inc. (ELVN) Snapshot price: $21.44
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.03% | -1.57K |
$30.00 | -$47,104.03 | 150.84K |
Scheduled
|
Oct 18
| ||
Form 4
| -1.01% | -1.27K |
$27.67 | -$35,143.31 | 124.49K |
Scheduled
|
Oct 15
| ||
Form 4
| -0.97% | -1.27K |
$22.41 | -$28,458.16 | 129.1K |
Scheduled
|
Sep 16
| ||
Form 4
| -0.96% | -1.27K |
$23.25 | -$29,526.20 | 130.37K |
Scheduled
|
Aug 15
| ||
Form 4
| -1.45% | -2.35K |
$27.51 | -$64,662.54 | 159.56K |
Scheduled
|
Jul 31
| ||
Form 4
| -0.94% | -1.27K |
$24.80 | -$31,496.76 | 133.34K |
Scheduled
|
Jul 15
| ||
Form 4
| -0.93% | -1.27K |
$21.48 | -$27,277.95 | 134.62K |
Scheduled
|
Jun 17
| ||
Form 4
| -0.93% | -1.27K |
$23.74 | -$30,149.67 | 135.88K |
Scheduled
|
May 16
| ||
Form 4
| -4.03% | -6.96K |
$23.34 | -$167,887.52 | 165.86K |
Scheduled
|
Apr 11 - Apr 15
| ||
Form 4
| -0.88% | -1.27K |
$14.50 | -$18,418.68 | 143.47K |
Scheduled
|
Mar 19
| ||
Form 4
| -0.87% | -1.27K |
$17.42 | -$22,117.43 | 144.74K |
Scheduled
|
Feb 15
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| -0.86% | -1.27K |
$16.41 | -$20,839.56 | 146.01K |
Scheduled
|
Jan 30
| ||
Form 4
| -0.12% | -216.00 |
$13.00 | -$2,808.00 | 176.5K |
Scheduled
|
Dec 21 - Dec 22
| ||
Form 4
| -2.36% | -4.28K |
$13.02 | -$55,727.05 | 176.71K |
Scheduled
|
Dec 19 - Dec 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
∞
| 218.4K |
—
|
—
| 218.4K |
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Receptos, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.40K |
—
|
—
|
0
|
Aug 27
| |||
Form 4
|
∞
| 7.4K |
—
|
—
| 7.4K |
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.6588
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
$139.26 | $832,318.28 |
0
|
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gritstone Oncology, Inc. (GRTS) Snapshot price: $0.47
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BCTG Acquisition Corp. (TNGX) Snapshot price: $10.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||